BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36382714)

  • 1. Pharmacokinetics of a single dose of Aficamten (CK-274) on cardiac contractility in a A31P MYBPC3 hypertrophic cardiomyopathy cat model.
    Sharpe AN; Oldach MS; Kaplan JL; Rivas V; Kovacs SL; Hwee DT; Morgan BP; Malik FI; Harris SP; Stern JA
    J Vet Pharmacol Ther; 2023 Jan; 46(1):52-61. PubMed ID: 36382714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy.
    Sharpe AN; Oldach MS; Rivas VN; Kaplan JL; Walker AL; Kovacs SL; Hwee DT; Cremin P; Morgan BP; Malik FI; Harris SP; Stern JA
    Sci Rep; 2023 Jan; 13(1):32. PubMed ID: 36593243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy.
    Rivas VN; Crofton AE; Jauregui CE; Wouters JR; Yang BS; Wittenburg LA; Kaplan JL; Hwee DT; Murphy AN; Morgan BP; Malik FI; Harris SP; Stern JA
    Sci Rep; 2024 May; 14(1):12038. PubMed ID: 38802475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of regional left ventricular systolic function by strain imaging echocardiography in phenotypically normal and abnormal Maine coon cats tested for the A31P mutation in the MYBPC3 gene.
    Pellegrino A; Daniel AG; Pereira GG; Itikawa PH; Larsson MH
    Can J Vet Res; 2017 Apr; 81(2):137-146. PubMed ID: 28408782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy.
    Longeri M; Ferrari P; Knafelz P; Mezzelani A; Marabotti A; Milanesi L; Pertica G; Polli M; Brambilla PG; Kittleson M; Lyons LA; Porciello F
    J Vet Intern Med; 2013; 27(2):275-85. PubMed ID: 23323744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study.
    Granström S; Godiksen MT; Christiansen M; Pipper CB; Martinussen T; Møgelvang R; Søgaard P; Willesen JL; Koch J
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S268-81. PubMed ID: 26776585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.
    Oldach MS; Ueda Y; Ontiveros ES; Fousse SL; Visser LC; Stern JA
    BMC Vet Res; 2021 Feb; 17(1):89. PubMed ID: 33622315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective echocardiographic and tissue Doppler imaging screening of a population of Maine Coon cats tested for the A31P mutation in the myosin-binding protein C gene: a specific analysis of the heterozygous status.
    Carlos Sampedrano C; Chetboul V; Mary J; Tissier R; Abitbol M; Serres F; Gouni V; Thomas A; Pouchelon JL
    J Vet Intern Med; 2009; 23(1):91-9. PubMed ID: 19175727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy.
    Meurs KM; Norgard MM; Kuan M; Haggstrom J; Kittleson M
    J Vet Intern Med; 2009; 23(4):840-3. PubMed ID: 19566849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine Coon and other breed cats.
    Wess G; Schinner C; Weber K; Küchenhoff H; Hartmann K
    J Vet Intern Med; 2010; 24(3):527-32. PubMed ID: 20412438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed.
    Mary J; Chetboul V; Sampedrano CC; Abitbol M; Gouni V; Trehiou-Sechi E; Tissier R; Queney G; Pouchelon JL; Thomas A
    J Vet Cardiol; 2010 Dec; 12(3):155-61. PubMed ID: 21051304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy.
    O'Donnell K; Adin D; Atkins CE; DeFrancesco T; Keene BW; Tou S; Meurs KM
    Anim Genet; 2021 Aug; 52(4):542-544. PubMed ID: 33970514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C.
    Stern JA; Rivas VN; Kaplan JL; Ueda Y; Oldach MS; Ontiveros ES; Kooiker KB; van Dijk SJ; Harris SP
    Sci Rep; 2023 Jun; 13(1):10319. PubMed ID: 37365215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of hypertrophic cardiomyopathy in cats and humans.
    Kittleson MD; Meurs KM; Harris SP
    J Vet Cardiol; 2015 Dec; 17 Suppl 1(Suppl 1):S53-73. PubMed ID: 26776594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy in young Maine Coon cats caused by the p.A31P cMyBP-C mutation--the clinical significance of having the mutation.
    Godiksen MT; Granstrøm S; Koch J; Christiansen M
    Acta Vet Scand; 2011 Feb; 53(1):7. PubMed ID: 21306647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cardiac myosin-binding protein C3 mutations in Maine Coon cats with hypertrophic cardiomyopathy.
    Sukumolanan P; Petchdee S
    Vet World; 2022 Feb; 15(2):502-508. PubMed ID: 35400937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
    Hsu A; Kittleson MD; Paling A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan.
    Akiyama N; Suzuki R; Saito T; Yuchi Y; Ukawa H; Matsumoto Y
    PLoS One; 2023; 18(4):e0283433. PubMed ID: 37071642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.
    Blass KA; Schober KE; Li X; Scansen BA; Bonagura JD
    J Vet Intern Med; 2014; 28(3):838-46. PubMed ID: 24597596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy in man and cats.
    Maron BJ; Fox PR
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S6-9. PubMed ID: 26776595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.